From: Myeloperoxidase modulation by LDL apheresis in Familial Hypercholesterolemia
FH (n = 8) | Controls (n = 8) | * p-value | |
---|---|---|---|
Total Cholesterol (mg/dl) | 343.1 ± 41.6 | 214.5 ± 32.0 | < 0.001 |
Triglycerides (mg/dl) | 196.1 ± 172.7 | 82.5 ± 41.4 | ns |
High Density Lipoprotein (mg/dl) | 50.9 ± 12.0 | 53.6 ± 10.5 | ns |
Low Density Lipoprotein (mg/dl) | 253.0 ± 47.7 | 144.4 ± 23.9 | < 0.001 |
C Reactive Protein (mg/dl) | 0.12 ± 0.08 | 0.08 ± 0.06 | ns |
C3c complement fraction (mg/dl) | 135.6 ± 22.1 | 92.6 ± 11.3 | < 0.001 |
C4 complement fraction (mg/dl) | 31.4 ± 15.7 | 19.6 ± 5.5 | ns |
Haptoglobin (mg/dl) | 114.6 ± 58.8 | 62.6 ± 26.5 | < 0.05 |
α1-Antitrypsin (mg/dl) | 151.7 ± 27.0 | 89.4 ± 12.3 | < 0.001 |
α2-Macroglobulin (mg/dl) | 183. ± 68.9 | 130.2 ± 31.5 | < 0.05 |
α1-acid Glycoprotein (mg/dl) | 81.5 ± 12.7 | 50.9 ± 4.7 | < 0.0001 |
Ceruloplasmin (mg/dl) | 24.2 ± 3.1 | 23.5 ± 6.7 | ns |
Myeloperoxidase (ng/dl) | 20.4 ± 3.3 | 1.9 ± 1.5 | < 0.01 |